Exploring androgen receptor variants in breast cancer and the development of thieno[2,3-b]pyridines as novel anti-cancer compounds.
Discover how gamma-tocotrienol (γT3), a natural compound from vitamin E, targets triple-negative breast cancer by suppressing androgen receptors and reversing epithelial-mesenchymal transition.